Integrative Bioinformatics Analysis of hsa-miR-21 in Breast Cancer Reveals a Prognostic Hub-Gene Signature
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27020865 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Maria Rosaria Tumolo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Research on Population & Social Policies, Research Unit of Brindisi, National Research Council, 72100 Brindisi, Italy. Hauptthemen laut MEDLINE: MicroRNAs, Breast Neoplasms, Computational Biology, Gene Expression Regulation, Neoplastic. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Breast cancer (BC) is the most frequently diagnosed malignancy in women and remains a leading cause of cancer-related mortality worldwide. Among the oncogenic microRNAs, hsa-miR-21 has been consistently implicated in tumorigenesis, yet a comprehensive network-level understanding of its regulatory landscape in BC is lacking. In this study, we performed an integrative bioinformatics analysis to characterize the molecular pathways and prognostic impact of hsa-miR-21. Experimentally validated mRNA targets were retrieved from miRTarBase and used to construct a high-confidence protein–protein interaction network via STRING, followed by hub-gene prioritization in Cytoscape. Functional enrichment analyses were conducted with DAVID to assess Gene Ontology (GO) categories and KEGG pathways. Survival analyses were performed in large BC cohorts from METABRIC and TCGA using the Kaplan–Meier Plotter. We identified 12 hub genes that are central regulators of apoptosis, proliferation, immune signaling, and transcriptional control. GO and KEGG analyses revealed enrichment in cancer-related, immune, and metabolic pathways, underscoring the pleiotropic role of miR-21. While miR-21 expression alone was not significantly associated with overall survival, a composite hub-gene signature demonstrated strong prognostic value. These findings highlight the importance of network-level biomarkers in BC and provide a reproducible framework for dissecting the clinical relevance of disease-associated miRNAs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Research on Population & Social Policies, Research Unit of Brindisi, National Research Council, 72100 Brindisi, Italy.
- Department of Physics and Chemistry "E. Segrè", University of Palermo, 90128 Palermo, Italy.
- Advanced Data Analysis in Medicine (ADAM), Laboratory of Interdisciplinary Research Applied to Medicine (DReAM), Local Health Authority (ASL) of Lecce, 73100 Lecce, Italy.
- Institute of Clinical Physiology, Branch of Lecce, National Research Council, 73100 Lecce, Italy.
- Department of Experimental Medicine, University of Salento, 73100 Lecce, Italy.
- Oncology Unit, 'Vito Fazzi' Hospital, 73100 Lecce, Italy.
ORCID-Profile: Roberto Guarino, Elisabetta De Matteis
Zitieren
APA
Tumolo, M. R., Conte, L., Guarino, R., De Giorgi, U., De Matteis, E., & Sabina, S. (2026). Integrative Bioinformatics Analysis of hsa-miR-21 in Breast Cancer Reveals a Prognostic Hub-Gene Signature. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27020865
Vancouver
Tumolo MR, Conte L, Guarino R, De Giorgi U, De Matteis E, Sabina S. Integrative Bioinformatics Analysis of hsa-miR-21 in Breast Cancer Reveals a Prognostic Hub-Gene Signature. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27020865
BibTeX
@article{Tumolo2026,
author = {Tumolo, Maria Rosaria and Conte, Luana and Guarino, Roberto and De Giorgi, Ugo and De Matteis, Elisabetta and Sabina, Saverio},
title = {Integrative Bioinformatics Analysis of hsa-miR-21 in Breast Cancer Reveals a Prognostic Hub-Gene Signature},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27020865}
}
EUVIMED